What Is KSM-66? The Ashwagandha Extract Behind 24+ Clinical Trials

What Is KSM-66 Ashwagandha?

KSM-66 is a patented, root-only ashwagandha extract made by Ixoreal Biomed, standardized to ≥5% withanolides using a solvent-free green chemistry process. It is the most clinically studied ashwagandha extract, with 24+ published human RCTs.

KSM-66 is a branded ashwagandha (Withania somnifera) extract made exclusively from the plant's roots, never the leaves. The name refers to both the ingredient and the proprietary extraction process behind it, developed by Ixoreal Biomed in Hyderabad, India.

Three features define KSM-66 and separate it from the hundreds of generic ashwagandha products on the market:

1. Root-only extraction. Ashwagandha's roots and leaves contain different withanolide profiles. The roots have been the basis of Ayurvedic use for over 3,000 years, and virtually all clinical trial data on stress, cortisol, and testosterone comes from root-based extracts. India's regulatory authority (FSSAI) has raised concerns about leaf-derived ashwagandha in therapeutic supplements. Ixoreal uses roots exclusively, despite leaves costing less than 1/15th the price (Ixoreal Biomed). This matters because the withanolide glycoside profiles in leaves differ from those in roots, and the clinical evidence base, particularly for stress, testosterone, and cognition, was built on root-only extracts. A 2025 clinical study specifically identified withanolide glycosides as the key drivers of bioavailability in ashwagandha extracts, further validating the root-only approach.

2. Green chemistry extraction. KSM-66 is produced without alcohol or synthetic solvents. The process — based on the traditional Ayurvedic Ksheerapaka method — uses water and milk to extract both hydrophilic and lipophilic compounds, preserving the root's full spectrum of bioactives. This took Ixoreal 14 years of R&D to commercialize (Chandrasekhar et al., 2012, Indian Journal of Psychological Medicine). See How Is KSM-66 Made? below for a full breakdown of the extraction process.

3. Withanolide standardization (≥5%). Withanolides are the steroidal lactones responsible for ashwagandha's adaptogenic effects. Generic ashwagandha powder contains 0.1–1% withanolides with no batch consistency. KSM-66 is standardized by HPLC to ≥5% — meaning every batch delivers the same potency used in its clinical trials. To put this in context: a 300 mg capsule of KSM-66 at 5% withanolides delivers ~15 mg of withanolides. Achieving the same withanolide intake from generic 1% ashwagandha powder would require ~1,500 mg, five times the weight. This is why extract ratio matters, and why comparing supplements by total milligrams alone is misleading.

Key specs: KSM-66 is manufactured by Ixoreal Biomed in Hyderabad, India, using a green chemistry extraction (water + milk, no alcohol or solvents) from roots only. Each batch is HPLC-verified at ≥5% withanolides with a ~10:1 extract ratio — meaning 300 mg of KSM-66 concentrates roughly 3,000 mg of raw root. The extract holds 46+ certifications including GRAS, USDA Organic, Non-GMO Project Verified, USP, and ISO 9001/14001/22000/45001. The standard clinical dose across 24+ published RCTs is 600 mg/day (300 mg twice daily).

---

What Does KSM-66 Do?

KSM-66 modulates the HPA (hypothalamic-pituitary-adrenal) axis to lower cortisol, support GABA activity, and reduce the hormonal effects of chronic stress — which downstream improves sleep, testosterone levels, cognition, and body composition.

KSM-66 works primarily through the hypothalamic-pituitary-adrenal (HPA) axis — the hormonal system that governs the body's stress response.

Under chronic stress, cortisol output stays elevated, which suppresses testosterone production, impairs sleep architecture, degrades cognitive function, and promotes visceral fat storage. KSM-66's withanolides act on this axis through several interconnected pathways:

Cortisol reduction. Chandrasekhar et al. (2012) measured a 27.9% reduction in serum cortisol over 60 days at 600 mg/day, compared to placebo. A 2025 meta-analysis of 15 RCTs confirmed this signal at high statistical significance (P < 0.0001) across 873 participants (Bachour et al., 2025, BJPsych Open).

GABAergic modulation. Ashwagandha acts as a GABA-mimetic, directly activating GABA_A and GABA_ρ receptors. This was demonstrated in a 2015 electrophysiology study that showed withanolides produce dose-dependent GABAergic currents in mammalian neurons (Candelario et al., 2015, Journal of Ethnopharmacology). This GABA pathway is likely responsible for ashwagandha's anxiolytic and sleep-promoting effects, independent of its cortisol action.

DHEA-S upregulation. DHEA-S is a testosterone precursor. By lowering cortisol, KSM-66 indirectly supports the hormonal environment for androgen production. Cortisol and DHEA-S compete for the same precursor (pregnenolone) in the adrenal steroidogenesis pathway. When cortisol demand drops, more pregnenolone is available for DHEA-S and downstream testosterone synthesis.

Inflammatory modulation. Withanolides have demonstrated NF-κB inhibition in preclinical models, which may contribute to the recovery and anti-fatigue effects observed in athletic populations. A 2026 RCT in 56 team sport athletes found that KSM-66 at 600 mg/day stabilized cortisol and cortisone responses during high-load pre-season training, with sex-specific benefits: improved recovery perception in women and greater lower-body strength gains in men (Coope et al., 2026, Nutrients).

The downstream effects — lower perceived stress, better sleep, improved testosterone, and sharper cognition are not separate mechanisms. They are consequences of the same HPA axis modulation. This is why KSM-66 tends to improve multiple outcomes simultaneously in clinical trials.

Dr. Ilene Ruhoy, MD, PhD — a double board-certified neurologist — reviews the clinical evidence for ashwagandha, including KSM-66 trials on stress, cognition, and sleep.

What Are the Benefits of KSM-66 Ashwagandha?

KSM-66's clinically validated benefits include a 27.9% reduction in cortisol (Chandrasekhar 2012), improved sleep quality (Langade 2019), a ~15% increase in testosterone in trained men (Wankhede 2015), enhanced memory and attention (Choudhary 2017), and increased VO₂max (Choudhary 2015) — all at 600 mg/day.

Every benefit listed here is backed by at least one published, peer-reviewed RCT using KSM-66 specifically. Where a benefit has been tested by a single trial only, that is noted.

Stress and Cortisol

The most replicated finding in KSM-66 research. Chandrasekhar et al. (2012) remains the landmark trial: 64 adults with chronic stress, 600 mg/day for 60 days, producing a 27.9% reduction in serum cortisol and significant reductions across all stress scales versus placebo (P<0.0001). The Perceived Stress Scale (PSS) fell 44%, the GHQ-28 stress measurement fell 72.3% from baseline, and the DASS fell 71.6%.

A 2025 meta-analysis of 15 RCTs and 873 participants (Bachour et al., BJPsych Open) confirmed that ashwagandha supplementation significantly reduces cortisol (P < 0.0001), perceived stress (P = 0.0013), and anxiety scores (P = 0.0007) in stressed adults. A separate 2022 dose-response meta-analysis reached similar conclusions but called for more high-quality trials.

A 2026 RCT in 56 team sport athletes (Coope et al., Nutrients) extended the cortisol data into athletic populations, showing that 600 mg/day of KSM-66 stabilized salivary cortisol and cortisone during high-load pre-season training — a period when placebo-group athletes showed rising stress hormones.

Sleep Quality

Langade et al. (2019, Cureus) tested KSM-66 at 600 mg/day in 80 participants for 8 weeks. The ashwagandha group showed significant improvements in sleep onset latency (fell asleep faster), total sleep time, and sleep quality versus placebo, as measured by both actigraphy (wrist-worn tracker) and the Pittsburgh Sleep Quality Index (PSQI).

A 2021 meta-analysis of five RCTs (400 participants) concluded that ashwagandha extract improves sleep, with the effect most pronounced at doses ≥600 mg/day for ≥8 weeks (Cheah et al., 2021, PLOS ONE). The NIH Office of Dietary Supplements notes that benefits in sleep research were more prominent at 600 mg/day and with treatment duration of at least 8 weeks — matching the KSM-66 dosing protocol exactly.

The sleep mechanism is likely dual: direct GABAergic activity (promoting sleep onset) and indirect cortisol reduction (removing a barrier to sustained deep sleep). Participants without insomnia who took ashwagandha also reported improved sleep quality, suggesting the effect is not limited to clinical sleep disorders.

Testosterone and Male Reproductive Health

Wankhede et al. (2015, JISSN) followed 57 resistance-trained men for 8 weeks: the KSM-66 group (600 mg/day) saw total testosterone increase ~15.3% versus placebo, alongside significantly greater gains in bench press (+46 kg vs +26.4 kg) and leg extension strength, and reduced exercise-induced muscle damage (lower creatine kinase levels). The study also reported greater increases in arm circumference (+8.6 cm² vs +5.3 cm²) and chest measurements (+3.3 cm vs +1.4 cm), and a more significant reduction in body fat percentage.

Ambiye et al. (2013, Evidence-Based Complementary and Alternative Medicine) tested 675 mg/day in oligospermic men and reported significant improvements in sperm concentration (+167%), semen volume (+53%), and sperm motility (+57%) over 90 days.

Mutha et al. (2025, Journal of Ayurveda and Integrative Medicine) confirmed improvements in total and free testosterone, sperm parameters, sexual desire, and erectile function at 600 mg/day — with no adverse events reported. A separate 2026 trial (Khanna et al., 2026) replicated these testosterone and sexual wellness findings, further strengthening the evidence base for KSM-66 in men's health.

Cognition and Memory

Choudhary et al. (2017, Journal of Dietary Supplements) tested 300 mg twice daily in 50 adults for 8 weeks. The KSM-66 group showed significant improvements in immediate and general memory (Wechsler Memory Scale), attention (reaction time), and information processing speed versus placebo.

A 2024 study using the COMPASS cognitive battery found KSM-66 improved working memory accuracy, attention, and processing speed in adults with self-reported cognitive complaints (published in Journal of Psychopharmacology). This trial is notable because it measured cognition directly via computerized testing rather than self-report questionnaires, providing more objective evidence for KSM-66's cognitive effects.

In 2026, the cognitive evidence extended to younger populations: Saxena et al. (2026, Frontiers in Nutrition) demonstrated that KSM-66 at 300 mg/day significantly improved episodic memory, working memory, attention, executive function, and information processing speed in children aged 6–12 years, with only mild adverse effects comparable to placebo.

Athletic Performance and Recovery

Choudhary et al. (2015, Journal of Ayurveda and Integrative Medicine) found that KSM-66 at 600 mg/day for 12 weeks significantly increased VO₂max in healthy athletic adults compared to placebo — a meaningful finding, since VO₂max is one of the hardest fitness metrics to move with any intervention.

The 2026 athlete study (Coope et al., Nutrients) added an important dimension: sex-specific responses. In 56 male and female team sport athletes (rugby, water polo, football) during 42 days of pre-season training, the KSM-66 group showed stabilized cortisol responses (while placebo athletes' cortisol rose), improved perceived recovery in women, and greater lower-body strength gains in men. This is the first RCT to demonstrate KSM-66's effects in both male and female competitive athletes simultaneously.

A completed 2025 RCT at Ramón Llull University (NCT07041853) examined KSM-66 for muscle strength and recovery in academy athletes, with results expected in 2026.

Weight and Body Composition

A completed 2025 trial (NCT07215455) evaluated KSM-66 at 300 mg/day for weight and stress management in overweight and obese adults. While full results are pending publication, the trial design — combining stress reduction with body composition outcomes — reflects the growing recognition that cortisol management is a component of metabolic health. Wankhede's 2015 strength training trial also reported a more significant reduction in body fat percentage in the KSM-66 group, suggesting that the combination of cortisol reduction and increased testosterone creates a favorable environment for body recomposition during resistance training.

Outcome	Key RCT	Dose	Duration	Result
Cortisol reduction	Chandrasekhar 2012	600 mg/day	60 days	−27.9% serum cortisol
Perceived stress	Chandrasekhar 2012	600 mg/day	60 days	−44% PSS / −72.3% GHQ-28
Sleep quality	Langade 2019	600 mg/day	8 weeks	Significant improvement (actigraphy + PSQI)
Testosterone	Wankhede 2015	600 mg/day	8 weeks	+15.3% total testosterone
Muscle strength	Wankhede 2015	600 mg/day	8 weeks	+46 kg bench press (vs +26.4 kg placebo)
Sperm parameters	Ambiye 2013	675 mg/day	90 days	+167% sperm concentration
Memory + cognition	Choudhary 2017	600 mg/day	8 weeks	Improved Wechsler Memory Scale scores
VO₂max	Choudhary 2015	600 mg/day	12 weeks	Significant VO₂max increase
Athlete cortisol	Coope 2026	600 mg/day	42 days	Stabilized cortisol during pre-season training
Children cognition	Saxena 2026	300 mg/day	8 weeks	Improved memory, attention, executive function

For a deeper look at how KSM-66 performs in specific populations, see our full guides: Ashwagandha for Men, Ashwagandha for Women, and Ashwagandha for Stress & Anxiety.

---

Does KSM-66 Boost Testosterone?

Yes, but modestly — and context matters. Wankhede et al. (2015) reported a ~15% increase in total testosterone over 8 weeks in resistance-trained men at 600 mg/day. The effect is indirect: KSM-66 lowers cortisol, which reduces HPA-mediated testosterone suppression.

The most cited figure comes from Wankhede et al. (2015), is a ~15% increase in total testosterone over 8 weeks in resistance-trained men taking 600 mg/day alongside a structured strength-training program. The placebo group also trained, but saw smaller hormonal changes. Lopresti et al. (2019) found similar directional effects in overweight men aged 40–70, though the magnitude varied by baseline stress levels — men with higher baseline cortisol saw larger testosterone responses.

The mechanism is indirect: KSM-66 lowers cortisol, which reduces HPA-mediated testosterone suppression. Cortisol and testosterone share a precursor (pregnenolone) in the adrenal steroidogenesis pathway. When the body's cortisol demand drops, more pregnenolone is available for DHEA-S and downstream testosterone synthesis. This means the effect is most meaningful in men who are chronically stressed, sleep-deprived, or overtraining — situations where cortisol is actively suppressing androgen production. In men with already-normal cortisol, the testosterone response is likely smaller.

Mutha et al. (2025) provided additional confirmation: 600 mg/day of KSM-66 significantly improved both total and free testosterone, along with sexual desire, erectile function, and quality of life measures in healthy men — with no adverse events.

One important clarification: KSM-66 is not an anabolic agent. A 15% increase in total testosterone within the physiological range does not produce steroid-like outcomes. It may, however, support the hormonal environment for strength adaptation and recovery, which is why the Wankhede trial saw both hormonal and performance improvements in combination.

See our detailed analysis: Ashwagandha for Men: Testosterone, Muscle & Fertility

---

How Much KSM-66 Should You Take Per Day?

Standard clinical dose: 600 mg/day, split into 300 mg twice daily (morning and evening) with meals.

This is the dose used in the majority of KSM-66's published RCTs — Chandrasekhar (2012), Langade (2019), Wankhede (2015), and Choudhary (2017) all used 600 mg/day. One fertility trial (Ambiye 2013) used 675 mg/day. The children's cognition trial (Saxena 2026) used 300 mg/day.

The dose is the same across goals: 600 mg/day. What changes is the timeline: stress and sleep improvements appear in 2–4 weeks, cortisol and testosterone shifts take 8+ weeks, and sperm parameter changes need 12+ weeks of consistent use.

Timing: Take with meals to improve absorption and reduce any GI discomfort. Splitting into two 300 mg doses maintains steadier blood levels throughout the day, though a 2024 pharmacokinetic study showed KSM-66 has a sustained-release profile that may support once-daily dosing for some users.

Start low if sensitive: Begin with 300 mg/day for the first week and increase to 600 mg/day if tolerated. The NIH Office of Dietary Supplements notes that adverse events in clinical trials were generally mild and comparable to placebo at doses up to 600 mg/day.

For a complete protocol with adjustment guidance, see our Ashwagandha Dosage Guide.

---

Does KSM-66 Have Side Effects?

Side effects are rare and mild. A 12-month safety study of 191 adults (Salve et al., 2025) and a 2026 systematic review of 23 RCTs with 2,317 participants (Pharmaceuticals) both concluded KSM-66 is well tolerated, with adverse events comparable to placebo. The most common report is temporary GI discomfort in the first week.

KSM-66 has one of the strongest safety records of any ashwagandha extract — and one of the strongest of any botanical supplement ingredient.

The most important safety data point came in 2025: Salve et al. (Phytotherapy Research) tracked 191 healthy adults taking KSM-66 at 600 mg/day for 12 full months — the longest ashwagandha safety study ever published. Liver function (ALT, AST, bilirubin), kidney function (creatinine, BUN), and thyroid parameters (TSH, T3, T4) all remained within normal reference ranges throughout. Adverse events were mild and self-limiting, with no serious adverse events attributed to the extract.

A 2026 systematic review (published in Pharmaceuticals) analyzed 23 RCTs with 2,317 total participants using standardized root-only ashwagandha extracts — the majority being KSM-66 — at doses ranging from 125 to 600 mg/day for up to 180 days. The review concluded that the safety profile is strong, adverse events are mild, and the overall tolerability is comparable to placebo. Additionally, a 2026 Frontiers in Nutrition study evaluated KSM-66 at doses higher than standard commercial levels and still found no safety concerns.

The most commonly reported side effect is mild GI discomfort (bloating or loose stools) during the first week, which typically resolves on its own — taking KSM-66 with food helps. Drowsiness is uncommon and more likely with evening doses, which may actually benefit sleep-focused users. Headache is rare and reported at similar rates in placebo groups across trials.

Who Should Not Take KSM-66

Pregnant or breastfeeding women. Ashwagandha has not been adequately studied in pregnancy. Some traditional texts classify it as an abortifacient at high doses. The NIH ODS recommends avoiding ashwagandha during pregnancy until more data is available.

People with hyperthyroidism or Graves' disease. Ashwagandha may increase thyroid hormone levels (Sharma et al., 2018), which is beneficial for subclinical hypothyroidism but potentially harmful for hyperthyroid conditions.

People on sedatives, thyroid medication, or immunosuppressants. Ashwagandha may amplify the effects of these drug classes. Consult your prescribing physician before combining.

Those with autoimmune conditions. Ashwagandha's immunomodulatory activity could theoretically stimulate already-overactive immune responses. While no clinical trial has reported autoimmune flares, the theoretical risk warrants caution.

For a full drug interaction list, see our Ashwagandha Interactions Guide. For a deeper side-effect review, see Ashwagandha Side Effects.

---

Is KSM-66 Better Than Regular Ashwagandha?

Yes. KSM-66 delivers ≥5% withanolides per batch with HPLC verification, while generic ashwagandha powder contains 0.1–1% with no consistency guarantee. KSM-66's 24+ RCTs were conducted with this specific extract — generic powder has virtually no clinical trial data of its own.

The practical implication: when you take a supplement containing KSM-66, you are taking the same extract, at the same potency, that was used in the published clinical trials. With generic ashwagandha, you are taking an unknown quantity of active compounds, and the trial data does not necessarily apply to what is in your capsule. A 2025 study specifically identified withanolide glycosides as the key drivers of bioavailability — meaning the type and ratio of withanolides matters, not just the total percentage on the label.

That said, KSM-66 is not the only standardized ashwagandha extract. Sensoril and Shoden are legitimate alternatives with their own clinical data.

For a full 24-trial comparison, see KSM-66 vs Regular Ashwagandha.

---

KSM-66 vs Sensoril vs Shoden: Which Extract Should You Choose?

Choose KSM-66 (600 mg/day) for stress, testosterone, and cognition — it has the deepest RCT data. Choose Sensoril (125–250 mg/day) for cortisol and relaxation at a lower dose. Choose Shoden (120–240 mg/day) for sleep, where its 35% withanolide concentration may offer faster onset.

Three branded ashwagandha extracts dominate the clinical literature. Each uses a different plant part, standardization target, and dose range.

Feature	KSM-66	Sensoril	Shoden
Manufacturer	Ixoreal Biomed	Natreon Inc.	Arjuna Natural
Plant part	Root only	Root + leaf	Root + leaf
Withanolides	≥5%	≥10%	≥35%
Clinical dose	600 mg/day	125–250 mg/day	120–240 mg/day
Published RCTs	24+	~8	~5
Best studied for	Stress, testosterone, cognition, strength	Stress, sleep, cortisol	Sleep, anxiety

The key difference is not which is "better" — it is which has been tested for your goal.

Stress + testosterone + strength: KSM-66 has the most data by far (Chandrasekhar, Wankhede, Ambiye).

Sleep + relaxation: Sensoril has strong cortisol data at lower doses; Shoden's higher withanolide concentration may produce faster sleep-onset effects.

General adaptogenic support: Any of the three, at their respective clinical doses, has reasonable evidence.

For a full buying guide with product comparisons, see Best Ashwagandha Supplements 2026.

---

How Long Does KSM-66 Take to Work?

Stress and sleep improvements typically appear within 2–4 weeks of daily use. Measurable cortisol reduction takes 4–8 weeks, testosterone changes require 8+ weeks, and sperm parameter improvements need 12+ weeks — based on RCT endpoints at 600 mg/day.

Most users report noticeable changes in stress perception and sleep quality within 2–4 weeks. Objective biomarker changes (cortisol, testosterone) take longer.

Weeks 1–2: Subtle changes in sleep quality and daytime stress tolerance. These are primarily driven by KSM-66's GABAergic activity, which has more immediate effects than HPA axis modulation.

Weeks 2–4: Perceived stress reductions become more noticeable. The Chandrasekhar trial measured at day 60 but reported significant interim improvements suggesting effects begin building in this window.

Weeks 4–8: Measurable cortisol reduction, sleep improvements confirmed by actigraphy (Langade 2019 measured at 8 weeks), and the beginning of cognitive improvements (Choudhary 2017 measured at 8 weeks).

Weeks 8–12: Testosterone changes measurable in blood work (Wankhede 2015 measured at 8 weeks). Strength and body composition changes become apparent in conjunction with resistance training.

Weeks 12+: Sperm parameter changes (Ambiye 2013, 90-day endpoint). VO₂max improvements (Choudhary 2015, 12-week endpoint).

KSM-66 is not a single-dose intervention. Its effects build with consistent daily use as the HPA axis recalibrates. Skipping doses or cycling on and off reduces the likelihood of replicating the trial outcomes. The 12-month safety study (Salve 2025) confirms that long-term daily use is safe and well tolerated.

For a complete timeline with user-reported milestones, see How Long Does Ashwagandha Take to Work?

---

How Is KSM-66 Made? The Extraction Process Explained

KSM-66 is extracted from ashwagandha roots using a 14-year-developed proprietary process based on the Ayurvedic Ksheerapaka (milk decoction) method — no alcohol, no synthetic solvents. The result is a full-spectrum extract that preserves the root's natural ratio of withanolides, alkaloids, and saponins.

Understanding how KSM-66 is made helps explain why it behaves differently from generic ashwagandha products — and why it costs more.

Step 1: Root Sourcing

KSM-66 starts with ashwagandha roots grown on dedicated farms in Rajasthan and Madhya Pradesh, India. Only roots are harvested — never leaves, stems, or berries. This is a deliberate choice: the price of ashwagandha leaves is often less than 1/15th the price of roots, and blending in leaves would significantly increase margins. Ixoreal has publicly stated that its founders rejected this approach on principle (Ixoreal Biomed). The farming follows sustainable agricultural practices, and the supply chain is fully traceable from field to finished extract.

Step 2: Green Chemistry Extraction

The extraction process is based on "green chemistry" principles — a term that means the process avoids environmentally harmful solvents. Most ashwagandha extracts on the market use alcohol (ethanol or methanol) or chemical solvents like hexane to pull out active compounds. These methods are efficient but can alter the natural ratio of bioactives, over-concentrating some compounds while destroying others.

KSM-66 uses only water and milk. The milk component is drawn from the traditional Ayurvedic Ksheerapaka preparation method, where herbs are decocted in milk to extract lipophilic (fat-soluble) compounds that water alone cannot reach. The milk proteins and fats act as natural carrier molecules, solubilizing the lipophilic withanolides while the water phase captures the hydrophilic alkaloids and saponins. The result is a "full-spectrum" extract — one that retains both classes of bioactives in their natural proportions, rather than isolating a single compound class.

This process took Ixoreal 14 years to develop and scale. The challenge was achieving a high concentration of withanolides (≥5%) without resorting to solvent-based concentration methods. The R&D investment is one reason KSM-66 commands a premium over generic extracts.

Step 3: Standardization and Testing

Every batch of KSM-66 is standardized to contain ≥5% total withanolides as measured by HPLC (High-Performance Liquid Chromatography). This is not a label claim. It is a verified analytical measurement performed on every production batch. The extract undergoes testing for heavy metals (lead, cadmium, mercury, arsenic), microbial contamination, pesticide residues, and solvent residues. Certificates of Analysis (COAs) are available for every batch.

KSM-66 holds over 46 international certifications, including GRAS (Generally Recognized As Safe) status from the FDA, USDA Organic, Non-GMO Project Verified, USP (United States Pharmacopeia) compliance, and ISO 9001/14001/22000/45001 certifications. It also holds British Pharmacopeia and Indian Pharmacopeia compliance. This certification stack is unusually deep for a single botanical ingredient and reflects the level of quality control infrastructure behind the extract.

Why the Extraction Method Matters

The extraction method directly affects what ends up in the capsule, and whether the clinical trial data applies to the product you are taking. KSM-66's RCTs were conducted using this specific extract, produced by this specific process. If a supplement uses a different extraction method (alcohol-based, leaf-inclusive, different withanolide standardization), the clinical data from KSM-66 trials cannot be assumed to transfer. This is the fundamental problem with generic ashwagandha: it may contain ashwagandha without containing the same bioactive profile that was clinically tested.

A vegan version of KSM-66 exists that omits the milk pre-treatment step. It is still standardized to ≥5% withanolides, but the overall bioactive profile may differ slightly because the lipophilic extraction step is modified. Both versions are manufactured by Ixoreal and carry the KSM-66 trademark.

---

Who Should Take KSM-66? (And Who Shouldn't)

KSM-66 is best suited for adults dealing with chronic stress, poor sleep, or training recovery needs. It is not appropriate for pregnant women, people with hyperthyroidism, or those on immunosuppressive or sedative medications without physician clearance.

Good Candidates for KSM-66

Adults under chronic stress. This is the population with the most robust evidence. If you experience sustained work stress, disrupted sleep from anxiety, elevated cortisol symptoms (weight gain around the midsection, afternoon energy crashes, difficulty winding down at night), or simply feel like your stress tolerance has degraded over time — the Chandrasekhar (2012) and Bachour (2025) data apply most directly to you.

Strength athletes and people who train hard. The combination of cortisol management, modest testosterone support, reduced muscle damage markers, and improved recovery perception (Wankhede 2015; Coope 2026) makes KSM-66 one of the few legal, evidence-backed performance supplements beyond creatine and caffeine. It will not replace sleep, nutrition, or programming, but it does address a dimension (stress physiology) that those interventions do not.

People with mild sleep difficulties. If your sleep issues are stress-driven rather than circadian (you can't shut your brain off, not that your sleep schedule is misaligned), the Langade (2019) data is relevant. KSM-66 is not a sedative. It works by lowering the cortisol and anxiety that prevent sleep onset.

Men interested in hormonal optimization. The testosterone data (Wankhede 2015; Mutha 2025) is most relevant for men whose testosterone is being suppressed by chronic stress, poor sleep, or overtraining — It is not a substitute for medical care in men with clinically diagnosed hypogonadism, which requires physician evaluation.

Students and professionals seeking cognitive support. The memory and attention improvements from Choudhary (2017) and the 2024 COMPASS cognitive battery trial suggest KSM-66 may help with focus and information processing — likely through the same stress-reduction pathway (cognitive function degrades under chronic cortisol exposure).

Who Should Avoid KSM-66

Pregnant or breastfeeding women — insufficient safety data; some traditional sources classify high-dose ashwagandha as potentially abortifacient.

People with hyperthyroidism or Graves' disease — ashwagandha may elevate thyroid hormones (Sharma et al., 2018).

Anyone on sedatives, thyroid medication, immunosuppressants, or blood sugar-lowering drugs — potential for additive or interactive effects. Always consult the prescribing physician.

People with active autoimmune conditions — theoretical risk of immune stimulation.

For everyone else, the 12-month safety data (Salve 2025) and the 2,317-participant systematic review (Pharmaceuticals, 2026) provide strong reassurance that daily KSM-66 at 600 mg is well tolerated over extended periods.

For a full drug interaction list, see our Ashwagandha Interactions Guide.

---

Key Takeaways

KSM-66 is the most clinically validated ashwagandha extract available. Twenty-four published RCTs — plus a 12-month safety study (Salve 2025) and a 2026 systematic review of 23 trials with 2,317 participants (Pharmaceuticals) — make it one of the best-evidenced botanical ingredients in the supplement market. The standard dose is 600 mg/day with meals, the safety profile is strong, and the evidence is strongest for stress reduction, sleep quality, testosterone support, and cognitive function.

Whether KSM-66 is the right choice depends on your goal. For stress, testosterone, and cognition, it has the deepest data. For pure sleep optimization, Sensoril and Shoden are reasonable alternatives. For general ashwagandha without the premium price, look for any root-only extract standardized to ≥2.5% withanolides with third-party testing — but know that the clinical evidence may not directly apply.

Our Ashwagandha Plus delivers 600 mg of KSM-66 per serving, matching the dose used in the cortisol, strength, and fertility trials. Every batch is third-party tested. Full lab results are published on our Lab Results page.

---

Every YourHealthier product referenced here is manufactured in an FDA-registered facility and undergoes independent third-party testing at accredited laboratories. Each batch is screened for heavy metals and microbial contamination. Full certificates of analysis are available on our Lab Results page.

yourhealthier.com